Supervised Brushing Programme for Intellectual Disabled Students

Status Not yet recruiting

Clinical Trial Summary

Intellectual disabled persons faced more dental problems. According to a medical review paper of international and local studies, this group has poorer dental hygiene, more severe gum disease and more untreated caries. In 2010, a report from the guardians in Hong Kong mentioned that most adults with intellectual disability cannot clean their teeth, the have dental problems and it is very difficult for intellectually disabled students to co-operate during the dental treatment. In order to alleviate their dental problems, supervised toothbrushing programme and an oral health education talk are proposed. The investigators investigate the effectiveness of the supervised toothbrushing programme and an oral health education talk. The target group of the study is mild to moderate grade intellectual disabled students of special schools in Hong Kong. A clustered randomised controlled trial design is adopted.

Clinical Trial Description

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03234231
Study type	Interventional
Source	MD Equation
Contact	Cecilia Young, BDS(HK),MPH
Phone	(+852) 23618684
Email	ceciliatyp@yahoo.com.hk
Status	Not yet recruiting
Phase	N/A
Start date	May 1, 2018
Completion date	December 31, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05935722` - Evaluation of a Home-based Parenting Support Program: Parenting Young Children	N/A
Completed	`NCT04020302` - Self-Monitoring Shopping Intervention	N/A
Active, not recruiting	`NCT03548779` - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2	N/A
Completed	`NCT03722212` - Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test	N/A
Not yet recruiting	`NCT03644797` - Second Molecular Event Identification by Exome Sequencing for Intellectually Disabled Patients Carrying 16p13.11 CNVs
Completed	`NCT03139760` - POWERSforID: A Telehealth Weight Management System for Adults With Intellectual Disability	N/A
Not yet recruiting	`NCT02881333` - Various Type of Genetic Events in Patients With Intellectual Disability	N/A
Completed	`NCT02746614` - Psychomotor Therapy Effects in Adaptive Behavior and Motor Proficiency in Intellectual Disability	N/A
Completed	`NCT06097819` - Therapy-Based Games' Effects on Motor and Cognitive Skills in Intellectual Disabilities	N/A
Recruiting	`NCT05767203` - Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin	N/A
Terminated	`NCT05445596` - Improving Treatment for Children With Intellectual and Developmental Disabilities and Problem Behavior in Schools	N/A
Recruiting	`NCT05131425` - Facing Your Fears: Adolescents With ASD and Intellectual Disability	N/A
Completed	`NCT04436692` - Dietary Intervention and Adults With Intellectual Disabilities	N/A
Completed	`NCT04518358` - Expert Guiding Technology to Help Individuals With Developmental Challenges Build Life and Vocational Skills	N/A
Completed	`NCT04917666` - Process and Outcomes of Horticultural Therapy for People With Disabilities	N/A
Completed	`NCT04554355` - Effects of a PA Intervention for Fatness and Fitness in Adolescents With Intellectual Disability	N/A
Completed	`NCT04277130` - Effectiveness of Active Video Games in Children With Intellectual Disabilities	N/A
Enrolling by invitation	`NCT02914951` - Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability	N/A
Completed	`NCT02304302` - Down Syndrome Memantine Follow-up Study	Phase 2
Completed	`NCT02591446` - Transcranial Magnetic Stimulation Studies in Autism Spectrum Disorders	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.